FDA Blocks Chinese Contract Manufacturer's OTC Topical Imports
Executive Summary
FDA says in a warning letter that Hangzhou Facecare Cosmetics's response to inspectors' findings following a June inspection was inadequate and the firm's imports in September were ordered detained without physical examination at all US ports.